Assuntos
Antifúngicos/administração & dosagem , Fluconazol/administração & dosagem , Griseofulvina/administração & dosagem , Tinha do Couro Cabeludo/tratamento farmacológico , Administração Oral , Antifúngicos/uso terapêutico , Esquema de Medicação , Feminino , Fluconazol/uso terapêutico , Griseofulvina/uso terapêutico , Humanos , Lactente , Recém-Nascido , MasculinoRESUMO
We provide a guide for dermatologists to follow if they encounter patients with a rash and clinical history suspicious of Zika virus infection, including diagnostic testing and management options. We also provide an illustrative case report of a patient from Brazil who was diagnosed with Zika virus infection after presenting with a generalized pruritic rash. One of the most prominent symptoms of Zika virus infection is a cutaneous eruption. As such, it is especially necessary for dermatologists to understand this virus so that they may appropriately recognize this entity as a diagnostic consideration in the clinic. The rash associated with Zika virus infection is most commonly an erythematous maculopapular eruption that presents after an initial 3-4 days of fever, headache, and arthralgia or myalgia. The rash typically lasts for an average of 6 days, and can spread to involve any part of the body, including the face, torso, extremities, palms, and soles.